Summary
- Current Price
- As of today, PLX price is $2.62, up +7.82% on
- Current Price All-Time High
- PLX price is currently -99.71% below its historical high of $912.50 set on
- Market Cap
- PLX current market cap is $211M, up +61.44% over the past 365 days
- PE Ratio
- PLX current PE ratio is 14.29
- Revenue
- PLX current annual revenue is $52.74M, down -1.23% year-over-year
- Next Earnings
- The next earnings release for PLX is on
Profile
| Metric | Value |
|---|---|
| Full Name | Protalix BioTherapeutics, Inc. |
| Ticker | NYSEAmerican: PLX |
| Exchange | NYSE American |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | protalix.com |
| Employees | 213 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| $2.62 | ||
| Price, 1D Change | +7.82% | |
| $211M | ||
| - | ||
| 14.29 | ||
| 1.36 | ||
| $52.74M | ||
| Revenue, 1Y Change | -1.23% | |
| -$0.08 | ||
| EPS, 1Y Change | -329.78% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:10 | |
| Next Split | N/A | N/A |
| Last Ticker Change | OTIX | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| -$0.08 | ||
| EPS Estimate | $0.20 | N/A |
| EPS Est. Change | +331.87% | N/A |
| $52.74M | ||
| Revenue Estimate | $78.30M | N/A |
| Revenue Est. Change | +48.45% | N/A |
| $2.62 | ||
| Price Target | $11.00 | - |
| Price Tgt. Change | +319.85% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.04 | - | |
| -$0.01 | -$0.08 | -1,582.00% | |
| $0.20 | N/A | +331.87% | |
| $0.05 | N/A | +159.45% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $53.93M | $53.40M | -0.98% | |
| $57.98M | $52.74M | -9.03% | |
| $78.30M | N/A | +48.45% | |
| $67.56M | N/A | +28.10% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Value | Date |
|---|---|---|
| +59.76% | ||
| +36.46% | ||
| +61.44% | ||
| +53.60% | ||
| -1.23% | ||
| +10.72% | ||
| -329.78% | ||
| +72.69% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Value | Date |
|---|---|---|
| $2.62 | ||
| $2.22 | ||
| $2.27 | ||
| $2.20 | ||
| $2.32 | ||
| $0.06 | ||
| 1.36 | ||
| $0.11 | ||
| 69.01 | ||
| 47.86% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $52.74M | ||
| -$0.08 | ||
| $25.24M | ||
| 47.85% | ||
| -$5.50M | ||
| -10.43% | ||
| -$6.60M | ||
| -12.52% | ||
| -$4.04M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| 0.17 | ||
| 2.51 | ||
| 1.54 | ||
| - | ||
| 6 | ||
| -1.83 |
Valuations
| Metric | Value | Date |
|---|---|---|
| 14.29 | ||
| 2.76 | ||
| 3.14 | ||
| 7.87 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| $48.23M | ||
| $30.98M | ||
| $82.35M | ||
| $66.67M | ||
| $34.12M | ||
| $26.52M | ||
| $8.32M | ||
| $1.38M | ||
| $5.26M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $59.35M | ||
| $31.25M | ||
| $27.51M | ||
| $0.00 | ||
| $1.47M | ||
| $0.00 | ||
| $996.00K |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$11.99M | ||
| -$2.37M | ||
| $9.33M | ||
| $1.64M | ||
| -$13.63M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → |
Analyst sentiment
Institutional ownership
Screeners with PLX
FAQ
- What is the ticker symbol for Protalix BioTherapeutics, Inc.?
- The ticker symbol for Protalix BioTherapeutics, Inc. is NYSEAmerican:PLX
- Does Protalix BioTherapeutics, Inc. pay dividends?
- No, Protalix BioTherapeutics, Inc. does not pay dividends
- What sector is Protalix BioTherapeutics, Inc. in?
- Protalix BioTherapeutics, Inc. is in the Healthcare sector
- What industry is Protalix BioTherapeutics, Inc. in?
- Protalix BioTherapeutics, Inc. is in the Biotechnology industry
- What country is Protalix BioTherapeutics, Inc. based in?
- Protalix BioTherapeutics, Inc. is headquartered in United States
- When did Protalix BioTherapeutics, Inc. go public?
- Protalix BioTherapeutics, Inc. initial public offering (IPO) was on May 15, 1998
- Is Protalix BioTherapeutics, Inc. in the S&P 500?
- No, Protalix BioTherapeutics, Inc. is not included in the S&P 500 index
- Is Protalix BioTherapeutics, Inc. in the NASDAQ 100?
- No, Protalix BioTherapeutics, Inc. is not included in the NASDAQ 100 index
- Is Protalix BioTherapeutics, Inc. in the Dow Jones?
- No, Protalix BioTherapeutics, Inc. is not included in the Dow Jones index
- When was Protalix BioTherapeutics, Inc. last earnings report?
- Protalix BioTherapeutics, Inc.'s most recent earnings report was on May 13, 2026
- When does Protalix BioTherapeutics, Inc. report earnings?
- The next expected earnings date for Protalix BioTherapeutics, Inc. is August 12, 2026
Data Sources & References
- PLX Official Website www.protalix.com
- PLX Profile on Yahoo Finance finance.yahoo.com/quote/PLX
- PLX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/plx